Author: Kreuter, A.; Licciardiâ€Fernandez, M. J.; Burmann, S.â€N.; Burkert, B.; Oellig, F.; Michalowitz, A.â€L.
Title: Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNAâ€based or adenoviral vectorâ€based SARSâ€CoVâ€2 vaccination Cord-id: 0klbjvrj Document date: 2021_9_13
ID: 0klbjvrj
Snippet: Evidence is accumulating that COVIDâ€19 vaccines might induce or exacerbate autoimmune rheumatic diseases. The currently available COVIDâ€19 vaccines include mRNA and recombinant adenoviral vector vaccines, both encoding SARSâ€CoVâ€2 spike protein production as the primary target for neutralizing antibodies. We report a case of subacute cutaneous lupus erythematosus (SCLE) following mRNA vaccination with the Pfizer mRNA vaccine BNT162b2, and summarize the current literature on CLE occurring
Document: Evidence is accumulating that COVIDâ€19 vaccines might induce or exacerbate autoimmune rheumatic diseases. The currently available COVIDâ€19 vaccines include mRNA and recombinant adenoviral vector vaccines, both encoding SARSâ€CoVâ€2 spike protein production as the primary target for neutralizing antibodies. We report a case of subacute cutaneous lupus erythematosus (SCLE) following mRNA vaccination with the Pfizer mRNA vaccine BNT162b2, and summarize the current literature on CLE occurring after COVIDâ€19 vaccination.[Image: see text]
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date